These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26921030)

  • 1. Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.
    Antanasijevic A; Kingsley C; Basu A; Bowlin TL; Rong L; Caffrey M
    J Biomol NMR; 2016 Mar; 64(3):255-65. PubMed ID: 26921030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.
    Chen BJ; Leser GP; Morita E; Lamb RA
    J Virol; 2007 Jul; 81(13):7111-23. PubMed ID: 17475660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology.
    Chlanda P; Schraidt O; Kummer S; Riches J; Oberwinkler H; Prinz S; Kräusslich HG; Briggs JA
    J Virol; 2015 Sep; 89(17):8957-66. PubMed ID: 26085153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylation Contributes to Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion.
    Chlanda P; Mekhedov E; Waters H; Sodt A; Schwartz C; Nair V; Blank PS; Zimmerberg J
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses.
    Barman S; Ali A; Hui EK; Adhikary L; Nayak DP
    Virus Res; 2001 Sep; 77(1):61-9. PubMed ID: 11451488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein.
    Ali A; Avalos RT; Ponimaskin E; Nayak DP
    J Virol; 2000 Sep; 74(18):8709-19. PubMed ID: 10954572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
    Jiang L; Changsom D; Lerdsamran H; Wiriyarat W; Masamae W; Noisumdaeng P; Jongkaewwattana A; Puthavathana P
    Arch Virol; 2016 Oct; 161(10):2693-704. PubMed ID: 27406044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
    Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.
    Thompson CM; Petiot E; Mullick A; Aucoin MG; Henry O; Kamen AA
    BMC Biotechnol; 2015 May; 15():31. PubMed ID: 25981500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.
    Zhang J; Pekosz A; Lamb RA
    J Virol; 2000 May; 74(10):4634-44. PubMed ID: 10775599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
    Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC
    Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
    Tao P; Luo M; Zhu D; Qu S; Yang Z; Gao M; Guo D; Pan Z
    Viral Immunol; 2009 Jul; 22(4):273-81. PubMed ID: 19594398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.
    Jin H; Leser GP; Zhang J; Lamb RA
    EMBO J; 1997 Mar; 16(6):1236-47. PubMed ID: 9135140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of influenza hemagglutinin interactions with receptor by NMR.
    McCullough C; Wang M; Rong L; Caffrey M
    PLoS One; 2012; 7(7):e33958. PubMed ID: 22815674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in hemagglutinin receptor-binding specificity accompany the emergence of highly pathogenic avian influenza viruses.
    Heider A; Mochalova L; Harder T; Tuzikov A; Bovin N; Wolff T; Matrosovich M; Schweiger B
    J Virol; 2015 May; 89(10):5395-405. PubMed ID: 25741006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.